Overview

The Center for Drug Repurposing at Ariel University, Israel is focused on uncovering new cures utilizing existing approved drugs in novel ways. The Center's Vision is "to alleviate suffering from disease through rapid realization of novel uses of existing drugs" Drug rediscovery is an innovative approach for drug development. Many approved medicinal products have multiple additional uses beyond those for which they have been approved. Discovering and developing new indications and innovative pharmaceutical forms and routes of administration usually leads to better, faster treatments at a greatly reduced financial risk. The ever rising bar of regulatory requirements, the steeply rising costs of clinical trials and the lack of candidates for new drug development has led to the rapid growth of the repurposed drug market. As of 2012, the number of repurposed drug candidate (505(b)(2)) approvals in the USA has exceeded that of new drugs and the exponential growth rate continues. Drug rediscovery delivers pharmaco-therapeutical progress and addresses unmet medical needs. The Center for Drug Repurposing partners with CureLeaders™ - the drug repurposing funding arm of We Fund The Cure - a US Not for Profit (505(c)(3)) organization. CureLeaders™ is focused on connecting public funders with research projects dedicated to drug repurposing. This enables us to cut down the time to provide study results to as little as 12 months from project initiation, The Center for Drug Repurposing and CureLeaders™ have teamed together to uncover novel cures for eye conditions, with a special focus on the widespread debilitating condition known as dry eye disease.